Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 15, Issue 5

September-October 2018

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Headlines from Washington
Image Challenge
Mini Review
News and Reports
Off the Shelf
President’s Column
Profiles

Ask the Hematologist

Treating Blastic Plasmacytoid Dendritic Cell Neoplasm

Marina Konopleva, MD, PhD,Naveen Pemmaraju, MD

View Articletitled, Treating Blastic Plasmacytoid Dendritic Cell Neoplasm

Clinical Trials Corner

Antibody Therapy in Acute Myeloid Leukemia Conditioning: Can We Improve Upon the Depth of Response?

Laura C. Michaelis, MD

View Articletitled, Antibody Therapy in Acute Myeloid Leukemia Conditioning: Can We Improve Upon the Depth of Response?

A New Strategy for the Prevention of Adverse Maternal and Fetal Outcomes in Pregnant Women With Sickle Cell Disease: The Oxygen Therapy and Pregnancy in SCD Trial (DR02G)

Michael DeBaun, MD, MPH

View Articletitled, A New Strategy for the Prevention of Adverse Maternal and Fetal Outcomes in Pregnant Women With Sickle Cell Disease: The Oxygen Therapy and Pregnancy in SCD Trial (DR02G)

Diffusion

Venous Thrombosis on One Side and Bleeding on the Other: How to Walk the Fence in Cancer Patients With Thrombosis and Thrombocytopenia

Lori-Ann Linkins, MD, MSc(Clin Epi), FRCPC

View Articletitled, Venous Thrombosis on One Side and Bleeding on the Other: How to Walk the Fence in Cancer Patients With Thrombosis and Thrombocytopenia

Microbial Signals May Drive Leukemia Development in Subjects With Clonal Hematopoiesis

Omar Abdel-Wahab, MD

View Articletitled, Microbial Signals May Drive Leukemia Development in Subjects With Clonal Hematopoiesis

Do Plasma Levels of Direct Oral Anticoagulants Correlate With Hemorrhagic and Thrombotic Complications?

Stephan Moll, MD

View Articletitled, Do Plasma Levels of Direct Oral Anticoagulants Correlate With Hemorrhagic and Thrombotic Complications?

Shedding Light on Migration of the Hematopoietic Niche Into Bone

Paul Moss, PhD

View Articletitled, Shedding Light on Migration of the Hematopoietic Niche Into Bone

JAK1/2 Inhibitors Linked to Aggressive B-cell Lymphoma Risk in Myelofibrosis and Pre-existing B-cell Clones May Mark Those at Risk

Sioban Keel, MD

View Articletitled, JAK1/2 Inhibitors Linked to Aggressive B-cell Lymphoma Risk in Myelofibrosis and Pre-existing B-cell Clones May Mark Those at Risk

Redefining Risks in Multiple Myeloma is Still a Work in Progress

Tarek H. Mouhieddine, MD,Irene M. Ghobrial, MD

View Articletitled, Redefining Risks in Multiple Myeloma is Still a Work in Progress

Not All Large Cells Are Created Equal: Is Genomic Classification the New Frontier in Diffuse Large B-cell Lymphoma?

Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA,Andrew Roberts, MBBS, PhD, FRACP, FRCPA

View Articletitled, Not All Large Cells Are Created Equal: Is Genomic Classification the New Frontier in Diffuse Large B-cell Lymphoma?

Refining and Redefining the Heterogeneity of DLBCL

Caron A. Jacobson, MD

View Articletitled, Refining and Redefining the Heterogeneity of DLBCL

Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?

Annette S. Kim, MD, PhD

View Articletitled, Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?

Headlines from Washington

ASH Officers Meet With Health and Human Services Leaders

ASH Staff

View Articletitled, ASH Officers Meet With Health and Human Services Leaders

Image Challenge

A Transplant Patient With Visual Disturbance

Steven Kroft, MD,Lyndsey Runaas, MD

View Articletitled, A Transplant Patient With Visual Disturbance

Mini Review

The Promise of Novel Therapies for β Thalassemia Syndromes

Sujit Sheth, MD

View Articletitled, The Promise of Novel Therapies for β Thalassemia Syndromes

News and Reports

Putting In the (Net)Work to Cure SCD

ASH Staff

View Articletitled, Putting In the (Net)Work to Cure SCD

Attend ASH-a-Palooza at the 2018 ASH Annual Meeting

Laura C. Michaelis, MD

View Articletitled, Attend ASH-a-Palooza at the 2018 ASH Annual Meeting

Off the Shelf

Off the Shelf: Stoner by John Williams

David P. Steensma, MD

View Articletitled, Off the Shelf: Stoner by John Williams

President’s Column

Broadening the Focus on Global Sickle Cell Efforts

Alexis Thompson, MD, MPH

View Articletitled, Broadening the Focus on Global Sickle Cell Efforts

Profiles

Mind Over Matter: One Person's Journey From Patient to Change-Maker

David-Zacharie Issom, MSc,Julie Kanter, MD

View Articletitled, Mind Over Matter: One Person's Journey From Patient to Change-Maker

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Treating Blastic Plasmacytoid Dendritic Cell Neoplasm

Clinical Trials Corner

Antibody Therapy in Acute Myeloid Leukemia Conditioning: Can We Improve Upon the Depth of Response?

A New Strategy for the Prevention of Adverse Maternal and Fetal Outcomes in Pregnant Women With Sickle Cell Disease: The Oxygen Therapy and Pregnancy in SCD Trial (DR02G)

Diffusion

Venous Thrombosis on One Side and Bleeding on the Other: How to Walk the Fence in Cancer Patients With Thrombosis and Thrombocytopenia

Microbial Signals May Drive Leukemia Development in Subjects With Clonal Hematopoiesis

Do Plasma Levels of Direct Oral Anticoagulants Correlate With Hemorrhagic and Thrombotic Complications?

Shedding Light on Migration of the Hematopoietic Niche Into Bone

JAK1/2 Inhibitors Linked to Aggressive B-cell Lymphoma Risk in Myelofibrosis and Pre-existing B-cell Clones May Mark Those at Risk

Redefining Risks in Multiple Myeloma is Still a Work in Progress

Not All Large Cells Are Created Equal: Is Genomic Classification the New Frontier in Diffuse Large B-cell Lymphoma?

Refining and Redefining the Heterogeneity of DLBCL

Circulating Tumor DNA in Lymphoma Monitoring: Fantasy, Fad, or Fact?

Headlines from Washington

ASH Officers Meet With Health and Human Services Leaders

Image Challenge

A Transplant Patient With Visual Disturbance

Mini Review

The Promise of Novel Therapies for β Thalassemia Syndromes

News and Reports

Putting In the (Net)Work to Cure SCD

Attend ASH-a-Palooza at the 2018 ASH Annual Meeting

Off the Shelf

Off the Shelf: Stoner by John Williams

President’s Column

Broadening the Focus on Global Sickle Cell Efforts

Profiles

Mind Over Matter: One Person's Journey From Patient to Change-Maker

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Headlines from Washington

Image Challenge

Mini Review

News and Reports

Off the Shelf

President’s Column

Profiles

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only